KoreaTimes - Bio

The Korea Times

The Korea Times

The Korea Times

Business

Bio

Sat, September 30, 2023 | 21:11

SK Biopharmaceuticals to unveil wearable devices at CES 2023

SK Biopharmaceuticals to unveil wearable devices at CES 2023

SK Biopharmaceuticals will unveil its wearable healthcare devices at the upcoming Consumer Electronics Show (CES) next month as part of its plan to advance into the digital healthcare business, its head of R&D said Wednesday. “The bio industry is changing by converging with ICT. We believe there will be a patient-centric period in the bio industry and we will try to lead the ...

Baek Byung-yeul | 2022-12-14 16:35

CHA Vaccine Institute to develop mixed vaccine for COVID-19, influenza

CHA Vaccine Institute to develop mixed vaccine for COVID-19, influenza

CHA Vaccine Institute is developing a mixed vaccine that can offer protection against both COVID-19 and influenza as part of its efforts to prevent multiple diseases with a single dose, the biotech company said Tuesday. The company said it has been developing the mixed vaccine using its own immunity-enhancing platform, L-pampo, to increase immunity against both COVID-19 and i...

2022-12-13 17:08

Gov't seeks to accelerate innovation in bio industry with AI, big data

Gov't seeks to accelerate innovation in bio industry with AI, big data

The government has unveiled a plan to speed up innovation in the biopharmaceutical industry by introducing advanced digital technologies such as artificial intelligence and big data, according to the Ministry of Science and ICT, Wednesday.

Kim Jae-heun | 2022-12-07 16:25

Seegene struggles to stay afloat as pandemic ebbs

Seegene struggles to stay afloat as pandemic ebbs

Seegene, which had enjoyed the soaring popularity of its COVID-19 PCR test kits, has been struggling to stay afloat as the pandemic has been ebbing, according to industry analysts, Monday. They said the time has passed for Seegene to enjoy high growth as the number of COVID-19 infections has gradually declined globally and much of the world is shifting to endemic mode.

Baek Byung-yeul | 2022-11-14 16:51

'Agility, digitalization are key edges of Samsung Biologics'

'Agility, digitalization are key edges of Samsung Biologics'

FRANKFURT - Samsung Biologics has been increasing its presence in the global contract development and manufacturing organization (CDMO) business, generating larger revenues than market expectations this year. Such growth was possible thanks to its agile response to improve production capacity and achieving a digital transformation, according to its executives, Tuesday.

Baek Byung-yeul | 2022-11-07 14:11

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

FRANKFURT - Robert Yu, president and CEO of Yuyu Pharma, said Wednesday that his mission is to make the company comparable to prominent biopharmaceutical companies in the world. To that end, he said the Korean company is actively diversifying its portfolio by developing new drugs such as a dry eye treatment as well as hair loss medication.

Baek Byung-yeul | 2022-11-06 11:51

Contract manufacturing emerges as new opportunity for Korean bio firms

Contract manufacturing emerges as new opportunity for Korean bio firms

FRANKFURT - The CPHI exhibition has become a place for finding new growth engines for Yungjin Pharm, Daewon Pharmaceutical, Kyongbo Pharm and other small Korean bio companies as they actively try to attract new clients for their contract manufacturing organization (CMO) business, according to the companies, Wednesday.

Baek Byung-yeul | 2022-11-03 16:09

New CEO vows to make SK pharmteco leading CDMO player

New CEO vows to make SK pharmteco leading CDMO player

FRANKFURT - Joerg Ahlgrimm, the new CEO of SK pharmteco, vowed Tuesday that his goal as a chief executive is to make the SK Group's contract development and manufacturing organization (CDMO) company one of the best players in the global cell and gene therapy (CGT) CDMO business. “We have technological leadership in the CDMO field and my goal is to create a significant competi...

Baek Byung-yeul | 2022-11-02 16:45

Samsung Biologics highlights essentials for global pharma-CDMO partnerships

Samsung Biologics highlights essentials for global pharma-CDMO partnerships

FRANKFURT - Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO) company that develops and produces drugs for its clients, said demand for biomedicine will exceed supply from 2026, adding that finding the best partner to outsource production is becoming more important for global pharmaceutical companies, according to its executive, Tue...

Baek Byung-yeul | 2022-11-01 19:05

Celltrion seeks new partnerships at CPhI bio exhibition

Celltrion seeks new partnerships at CPhI bio exhibition

FRANKFURT - Celltrion, a Korea-based biopharmaceutical company, is seeking to secure new partnerships at the CPhI bio pharmaceutical exhibition by opening an independent booth, the company said Tuesday. The exhibition is held every year touring major European cities. This year's event is in Frankfurt, Germany, for three days through Thursday, providing opportunities for medic...

Baek Byung-yeul | 2022-11-01 16:35

1 2 3 4 5 6 7 8 9 10

Top 10 Stories

1	Guide to Chuseok celebrations across Korea

2	Chuseok exodus begins ahead of extended 6-day holiday

3	Korea sees record-low births in July

4	Hyundai E&C to build upmarket apartment complex in Seoul's Gwanak District

5	Political battle intensifies after court rejects Lee's arrest warrant

6	Korea on track to prove esports prowess at Asian Games

7	INTERVIEWRisk-averse culture is forcing daring creators to flee showbiz

8	Lotte focuses on health care, mobility to spur growth

9	DMZ Open Int'l Music Festival to be held in Goyang in November

10	Two Koreas trade barbs over nuclear war

DARKROOM